Stock Scorecard
Stock Summary for Stoke Therapeutics Inc (STOK) - $19.76 as of 8/29/2025 9:12:55 PM EST
Total Score
14 out of 30
Safety Score
41 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for STOK
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for STOK
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for STOK
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for STOK
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for STOK (41 out of 100)
| Stock Price Rating (Max of 10) | 6 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for STOK
Financial Details for STOK
Company Overview |
|
|---|---|
| Ticker | STOK |
| Company Name | Stoke Therapeutics Inc |
| Country | USA |
| Description | Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops new antisense oligonucleotide (ASO) drugs to treat the underlying causes of serious genetic diseases in the United States. The company is headquartered in Bedford, Massachusetts. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/11/2025 |
Stock Price History |
|
| Last Day Price | 19.76 |
| Price 4 Years Ago | 23.99 |
| Last Day Price Updated | 8/29/2025 9:12:55 PM EST |
| Last Day Volume | 623,527 |
| Average Daily Volume | 965,562 |
| 52-Week High | 19.96 |
| 52-Week Low | 5.35 |
| Last Price to 52 Week Low | 269.35% |
Valuation Measures |
|
| Trailing PE | 22.18 |
| Industry PE | 40.47 |
| Sector PE | 60.89 |
| 5-Year Average PE | -3.01 |
| Free Cash Flow Ratio | 10.68 |
| Industry Free Cash Flow Ratio | 15.46 |
| Sector Free Cash Flow Ratio | 30.76 |
| Current Ratio Most Recent Quarter | 6.98 |
| Total Cash Per Share | 1.85 |
| Book Value Per Share Most Recent Quarter | 6.12 |
| Price to Book Ratio | 3.16 |
| Industry Price to Book Ratio | 28.68 |
| Sector Price to Book Ratio | 26.74 |
| Price to Sales Ratio Twelve Trailing Months | 5.29 |
| Industry Price to Sales Ratio Twelve Trailing Months | 25.19 |
| Sector Price to Sales Ratio Twelve Trailing Months | 13.32 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 54,797,000 |
| Market Capitalization | 1,082,788,720 |
| Institutional Ownership | 120.01% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 15.01% |
| Reported EPS 12 Trailing Months | 0.87 |
| Reported EPS Past Year | 1.50 |
| Reported EPS Prior Year | -1.68 |
| Net Income Twelve Trailing Months | 52,484,000 |
| Net Income Past Year | -88,981,000 |
| Net Income Prior Year | -104,699,000 |
| Quarterly Revenue Growth YOY | 186.00% |
| 5-Year Revenue Growth | 0.00% |
| Operating Margin Twelve Trailing Months | -197.60% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 101,472,000 |
| Total Cash Past Year | 127,983,000 |
| Total Cash Prior Year | 191,442,000 |
| Net Cash Position Most Recent Quarter | 101,472,000 |
| Net Cash Position Past Year | 127,983,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 229,021,000 |
| Total Stockholder Equity Prior Year | 159,565,000 |
| Total Stockholder Equity Most Recent Quarter | 334,943,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 61,146,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 1.12 |
| Free Cash Flow Past Year | -87,054,000 |
| Free Cash Flow Prior Year | -82,683,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.78 |
| MACD Signal | 1.54 |
| 20-Day Bollinger Lower Band | 5.64 |
| 20-Day Bollinger Middle Band | 12.21 |
| 20-Day Bollinger Upper Band | 18.78 |
| Beta | 1.15 |
| RSI | 72.82 |
| 50-Day SMA | 11.18 |
| 150-Day SMA | 9.83 |
| 200-Day SMA | 11.89 |
System |
|
| Modified | 8/28/2025 11:09:53 AM EST |